Juvederm vs. Restylane: which is better

Why Juvederm and Restylane dominate the HA filler conversation

You are deciding between Juvederm and Restylane, and the marketing from both sides makes it hard to separate real differences from spin. The Juvederm vs Restylane question does not have a single answer because neither brand is universally better. Both are families of FDA-approved hyaluronic acid dermal fillers, not single products. The useful comparison is between specific products within each portfolio, not the brand names on the box.

Juvederm is manufactured by AbbVie's Allergan Aesthetics division, and Restylane by Galderma. Both companies produce multiple fillers built on different cross-linking technologies, each designed for specific facial areas and outcomes. The right choice depends on your anatomy, your goals, and which product your injector recommends for the area being treated. ASPS 2024 data shows that soft tissue fillers remain popular with patients aged 40 to 54, who account for 50% of patients undergoing the procedure. The sections below cover gel technology, product lines by treatment area, longevity, safety and reversibility, and cost so you can make an informed decision.

Juvederm vs. Restylane at a glance

The fastest way to understand the difference is to look at the core specifications side by side. Manufacturer, gel behavior, and treatment-area match determine your result more than comparing brand names in isolation. This table summarizes the eight factors that matter most.

Restylane offers four distinct cross-linking technologies (NASHA, OBT, XpresHAn, and NASHA HD) versus Juvederm's two (VYCROSS and Hylacross). This gives clinicians more options to match gel behavior to anatomical needs. The differences in G-prime, cohesivity, and water absorption explain why certain products work better in specific facial areas.

The science behind the gels: VYCROSS, NASHA, and cross-linking technology

Hyaluronic acid is a molecule your body produces naturally in skin and connective tissue, where it binds water and maintains volume and hydration. In dermal fillers, HA is synthetically produced and then cross-linked. This chemical process binds HA chains together into a stable gel that resists rapid breakdown in the body.

Juvederm's VYCROSS technology blends high and low molecular weight HA chains with efficient cross-linking, producing a smooth, cohesive monophasic gel that spreads evenly and absorbs more water. The term monophasic means the gel is a single, homogeneous mixture rather than particles in suspension. Its older Hylacross platform, used in Ultra XC and Ultra Plus XC, creates a smoother, more fluid consistency. The higher water absorption of VYCROSS gels means patients may see a plumper result, but also slightly more post-injection swelling.

Restylane's NASHA (Non-Animal Stabilized Hyaluronic Acid) platform produces a particulate gel with discrete particles suspended in carrier fluid. Particle size varies by product. Restylane Silk has approximately 200,000 particles per mL for fine lines, while Restylane Lyft has about 8,000 particles per mL for deep volume. NASHA products have high G-prime, meaning firmness and structural support, but lower cohesivity, so they stay where placed for precise sculpting. Restylane's OBT (Optimal Balance Technology) and XpresHAn platforms produce flexible gels designed for dynamic areas. OBT gels can deform up to 1,442% before yielding, compared to NASHA's 7–19% xStrain values. This flexibility makes them better suited for areas that move with expression.

Two rheologic properties drive most placement decisions. G-prime measures a gel's firmness, or resistance to deformation. Cohesivity measures how well the gel holds together under pressure. High G-prime products suit structural areas like cheeks and jawline. For context, Juvederm Voluma XC has a G-prime of approximately 210 Pa, while Restylane Lyft measures around 799 Pa. Lower G-prime products work better in mobile areas like lips. Juvederm is more hydrophilic, meaning it absorbs more water for a plumper result. Restylane absorbs less water, producing more subtle, structured results.

Product lines and which treatment areas each targets

Comparing Juvederm and Restylane by facial area helps you find the right product for your specific concern. Each brand offers products with different gel properties designed for particular areas of the face. Here is how the product lines break down by treatment area, with FDA-approved indications and typical duration for each product.

For cheek and midface volume, Juvederm Voluma XC (VYCROSS, HA 20 mg/mL, G-prime ~210 Pa) provides cohesive, smooth volume. It is FDA-approved for age-related volume loss in the midface. Restylane Lyft (NASHA, G-prime ~799 Pa) offers firmer, particulate lift on bone and is FDA-approved for cheek and hand volume loss. Restylane Contour uses XpresHAn technology for midface contour deficiencies.

For lip augmentation, Juvederm Ultra XC (Hylacross, 6–12 months) provides plump fullness. Juvederm Volbella XC (VYCROSS, HA 15 mg/mL, ~12 months) offers subtle volume and also treats perioral lines. On the Restylane side, Restylane Kysse uses XpresHAn technology for a lifelike, pliant texture, and Restylane Silk (6–9 months) targets fine perioral lines with its small-particle formulation. Our lip filler treatments use products from both lines depending on your goals.

For nasolabial folds and moderate lines, Juvederm Vollure XC (VYCROSS, HA 17.5 mg/mL, 12–18 months) addresses moderate wrinkles. Restylane Defyne (OBT, ~12 months) targets deeper nasolabial folds and is also FDA-approved for chin augmentation. Restylane Refyne (OBT, ~12 months) handles fine lines and perioral areas with flexibility.

For jawline and chin definition, Juvederm Volux XC (VYCROSS, HA 23.5 mg/mL, G-prime ~320 Pa) is the highest-G-prime VYCROSS product, designed for jawline projection. Restylane Defyne is FDA-approved for chin augmentation, offering a flexible alternative for chin contouring.

For under-eye hollows, Juvederm Volbella XC, with its low HA concentration of 15 mg/mL, produces minimal swelling. Restylane Eyelight is NASHA-based and designed specifically for infraorbital hollow correction, absorbing less water for a more structured result. A 2023 hyaluronidase study identified the under-eye as a less forgiving area where more easily dissolvable fillers may be a prudent choice. Some under-eye uses are off-label and should be discussed with a qualified injector.

A clinic can cover most facial indications with three products from either family: Juvederm (Voluma + Vollure + Volbella) or Restylane (Lyft + Defyne + Kysse). Our dermal filler and facial balancing services use this approach to match each product to the right area.

How long Juvederm and Restylane last: longevity compared

There is no family-wide winner on longevity. Duration varies by specific product, treated area, and individual metabolism.

Juvederm longevity by product: Voluma XC lasts up to 24 months in the cheeks. Vollure XC lasts 12–18 months in smile lines. Ultra XC lasts 6–12 months in the lips. Volbella XC lasts approximately 12 months in the lips and under-eye area.

Restylane longevity by product: Lyft lasts 12–18 months in the cheeks. Defyne and Refyne last approximately 12 months in smile lines. Silk lasts 6–9 months in the lips. Kysse lasts 6–9 months in the lips.

VYCROSS gels tend to outlast comparable NASHA and XpresHAn products by a few months in the same anatomic zone, particularly for deep-tissue volumizers like Voluma versus Lyft. This difference comes from higher cross-link density and slower enzymatic degradation, which is also why Voluma requires more hyaluronidase to dissolve than Restylane-L gram for gram. The average HA filler duration across both brands ranges from 6 to 18 months depending on the specific product and treatment area.

Restylane's firmer, more particulate structure keeps it in place structurally. This can be an advantage for sculpting areas like the jawline, where precise placement matters more than water retention. Lifestyle factors affect longevity across both brands: metabolism, injection depth, product volume, and the area treated. High-movement areas like lips break down faster than low-movement areas like cheeks.

Safety, side effects, and reversibility

Both Juvederm and Restylane are FDA-approved HA fillers with similar safety profiles. Common side effects include redness, swelling, tenderness, and bruising for several days after injection. Juvederm may cause slightly more swelling due to its higher water absorption and HA concentration.

The Tyndall effect, a blue tint under the skin from superficial placement, is an uncommon risk with both brands, particularly in the under-eye area. Proper injection depth and technique minimize this risk.

The reversibility advantage is significant. Both are HA fillers, so both can be dissolved with hyaluronidase, an enzyme that breaks down HA gel. This is a major safety benefit compared to non-HA fillers like Sculptra or Radiesse, which cannot be reversed.

A 2023 peer-reviewed study published in Plastic and Reconstructive Surgery Global Open tested 21 HA fillers and found wide variation in how easily they dissolve. Restylane-L and Restylane Lyft were among the least resistant to hyaluronidase, dissolving with as little as 2.5 units per 0.2 mL. Juvederm Ultra XC required 5-10 units per 0.2 mL. Juvederm Voluma was among the most resistant, requiring more than 20 units per 0.2 mL. The study's authors noted that in less forgiving areas like the under-eye, more easily dissolvable fillers may be a prudent choice.

Injector skill is the most important safety factor. Vascular occlusion is a rare but serious risk that an experienced, credentialed injector can avoid through proper technique and anatomical knowledge. All fillers at our clinic are administered by certified injectors using only FDA-approved products sourced directly from manufacturers.

Cost comparison: what you can expect to pay

The American Society of Plastic Surgeons reports an average cost of $715 per syringe for hyaluronic acid fillers and $743 for lip augmentation with dermal fillers. These are national averages; actual prices vary by geographic location, injector experience, and the specific product chosen.

Per-syringe ranges for Juvederm products typically run from $600-800 for Ultra XC to $800-1,200 for Voluma XC. Volbella XC sits at $650-850, Vollure XC at $700-900, and Volux XC at $900-1,200. Restylane products range from $550-700 for Silk to $700-1,000 for Lyft, with Kysse at $600-900.

Boston and other coastal metros tend to run higher than the national average. Many practices offer package pricing for multiple syringes, which can reduce the per-syringe cost by 10–20%. Health insurance does not cover cosmetic dermal fillers. The specific product chosen also affects price. A syringe of Juvederm Volux XC for jawline contouring will cost more than a syringe of Restylane Silk for fine lines, regardless of brand.

The number of syringes needed depends on the treatment area and desired outcome. A consultation is the only reliable way to determine how many syringes will achieve your goals.

Takeaways

• Juvederm and Restylane are families of FDA-approved HA fillers, not single products. Compare specific products within each portfolio, not brand names.
• Gel technology drives results: VYCROSS gels are smooth, cohesive, and absorb more water. NASHA gels are firmer and more particulate. OBT and XpresHAn gels flex with expression.
• Longevity varies by product and area: 6–18 months across both brands, with VYCROSS gels tending to last slightly longer in the same anatomic zone.
• Both are reversible with hyaluronidase, but dissolution speed varies by product. Restylane-L dissolves faster; Juvederm Voluma is more resistant.
• The right filler depends on your anatomy, goals, and your injector's product-to-area matching, not on which brand is better.

Your next step: book a no-pressure consultation at Purely Medspa

Neither Juvederm nor Restylane is universally better. The right filler depends on your anatomy, your goals, and the product-to-area match your injector recommends. Our nurse-practitioner led, physician-supervised team provides personalized, documented treatment plans with standardized photography. A zero-commission model means clinicians recommend only what you need, with no treating on consultation day unless you request it.

Book a no-pressure consultation to discuss your goals and receive a written treatment plan from a clinician who will be your injector for every visit.